Completed NA INTERVENTIONAL 3-arm
NCT06879288
Dexmedetomidine Versus Magnesium Sulfate as Adjuvants to Intraperitoneal Bupivacaine for Postoperative Analgesia After Elective Laparoscopic Cholecystectomy
Efficacy of Dexmedetomidine Versus Magnesium Sulfate as Adjuvants to Intraperitoneal Bupivacaine for Postoperative Analgesia in Patients Undergoing Elective Laparoscopic Cholecystectomy
Sponsor: Tanta University
Conditions
Adjuvants Dexmedetomidine Elective Laparoscopic Cholecystectomy Intraperitoneal Bupivacaine Magnesium Sulfate Postoperative Analgesia
Interventions
Bupivacaine Dexmedetomidine Magnesium sulfate
Updated 1 time since 2025 Last updated: Mar 11, 2025 Started: Jul 1, 2023 Primary completion: Feb 1, 2025 Completion: Feb 1, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Adjuvants and Dexmedetomidine and is currently completed. Tanta University leads this study, which shows 1 recorded version since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Tanta University
Data source: Tanta University
For direct contact, visit the study record on ClinicalTrials.gov .